Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Adaptive immune receptor repertoire analysis
B cell and T cell receptor repertoires compose the adaptive immune receptor repertoire
(AIRR) of an individual. The AIRR is a unique collection of antigen-specific receptors that …
(AIRR) of an individual. The AIRR is a unique collection of antigen-specific receptors that …
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application
Z Huang, Y Fu, H Yang, Y Zhou, M Shi, Q Li, W Liu… - Molecular Cancer, 2024 - Springer
T-cell lymphoma is a highly invasive tumor with significant heterogeneity. Invasive tissue
biopsy is the gold standard for acquiring molecular data and categorizing lymphoma …
biopsy is the gold standard for acquiring molecular data and categorizing lymphoma …
Molecular monitoring of lymphomas
Molecular monitoring of tumor-derived alterations has an established role in the surveillance
of leukemias, and emerging nucleic acid sequencing technologies are likely to similarly …
of leukemias, and emerging nucleic acid sequencing technologies are likely to similarly …
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance
S Zhang, X Wang, Z Yang, M Ding, M Zhang… - Frontiers in …, 2024 - frontiersin.org
Lymphoma is a highly heterogeneous lymphohematopoietic tumor. As our understanding of
the biological and pathological characteristics of lymphoma improves, we are identifying an …
the biological and pathological characteristics of lymphoma improves, we are identifying an …
The minimal residual disease using liquid biopsies in hematological malignancies
R Colmenares, N Álvarez, S Barrio, J Martínez-López… - Cancers, 2022 - mdpi.com
Simple Summary Monitoring the response to treatment in hematologic malignancies is
essential in defining the best way to optimize patient management. In general, achieving a …
essential in defining the best way to optimize patient management. In general, achieving a …
Higher 13‐Gene‐Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T‐Cell Lymphoma Patients
C Chen, L Huang, Z Chen, Q Ou, S Liu… - Advanced …, 2023 - Wiley Online Library
Exome sequencing of in situ tumor samples reveals that mutated genes can predict the
prognosis of patients with T‐cell lymphoma (TCL). However, how tumor mutation burden …
prognosis of patients with T‐cell lymphoma (TCL). However, how tumor mutation burden …
A genetic profiling guideline to support diagnosis and clinical management of lymphomas
M Sánchez-Beato, M Méndez, M Guirado… - Clinical and …, 2024 - Springer
The new lymphoma classifications (International Consensus Classification of Mature
Lymphoid Neoplasms, and 5th World Health Organization Classification of Lymphoid …
Lymphoid Neoplasms, and 5th World Health Organization Classification of Lymphoid …
Liquid biopsies and minimal residual disease in lymphoid malignancies
Minimal residual disease (MRD) assessment using peripheral blood instead of bone marrow
aspirate/biopsy specimen or the biopsy of the cancerous infiltrated by lymphoid …
aspirate/biopsy specimen or the biopsy of the cancerous infiltrated by lymphoid …
[HTML][HTML] Clinical use of circulating tumor DNA analysis in patients with lymphoma
B Bisig, K Lefort, S Carras, L de Leval - Human pathology, 2024 - Elsevier
The analysis of circulating tumor DNA (ctDNA) in liquid biopsy specimens has an
established role for the detection of predictive molecular alterations and acquired resistance …
established role for the detection of predictive molecular alterations and acquired resistance …
[HTML][HTML] Circulating tumor DNA-based genoty** and monitoring for predicting disease relapses of patients with peripheral T-cell lymphomas
SJ Kim, YJ Kim, SE Yoon, KJ Ryu, B Park… - Cancer Res …, 2023 - synapse.koreamed.org
Purpose Plasma circulating tumor DNA (ctDNA) could reflect the genetic alterations present
in tumor tissues. However, there is little information about the clinical relevance of cell-free …
in tumor tissues. However, there is little information about the clinical relevance of cell-free …